VIDEO: Imugene soars 5.5% after signing a new trial supply agreement with Merck & Pfizer.
Business news
Your browser doesn't support video. Visit Grafa
The Australian market is following Wall Street?s lead to trade lower today, weighed down by heavy losses for the miners. Imugene is surging 5.5% today after the biotech company announced a new clinical trial supply agreement with Merck and Pfizer. Lovisa is rallying today on the back of a bullish broker note out of Macquarie which said Lovisa has strong growth opportunities in the Chinese and Indian markets. Snapchat is adding TikTok-like AR music lenses through a new deal with Sony Music Entertainment, allowing Snap users to access songs from Sony?s artists, in a bid to better compete with TikTok for user engagement.